论文部分内容阅读
目的:观察注射用双黄连冻干粉治疗急性上呼吸道感染的临床疗效。方法:将符合急性上呼吸道感染诊断的56例患者随机分为两组,均予头孢呋辛钠抗炎及对症治疗,治疗组加用注射用双黄连冻干粉静滴,对照组加用利巴韦林注射液静滴。结果:两组总有效率相似,但治疗组治愈率高于对照组(P<0.05);与对照组比较,治疗组临床症状、体征、改善时间均明显缩短(P<0.05)。结论:注射用双黄连冻干粉治疗急性上呼吸道感染疗效满意。
Objective: To observe the clinical efficacy of Shuanghuanglian freeze-dried powder for the treatment of acute upper respiratory tract infection. Methods: Fifty-six patients who were diagnosed as acute upper respiratory tract infection were randomly divided into two groups. Both were given anti-inflammatory and symptomatic treatment of cefuroxime sodium. The treatment group was given intravenous injection of Shuanghuanglian injection, Barbara injection intravenous infusion. Results: The total effective rate was similar in both groups, but the cure rate of the treatment group was higher than that of the control group (P <0.05). Compared with the control group, the clinical symptoms, signs and improvement time of the treatment group were significantly shortened (P <0.05). Conclusion: The injection of Shuanghuanglian freeze-dried powder in the treatment of acute upper respiratory tract infection with satisfactory results.